Hypera SA operates in the Pharmaceutical preparations sector.
In addition to historical fundamental analyses, the complete report available to purchase compares Hypera SA with three other
pharmaceutical manufacturers in Latin America:
Instituto Hermes Pardini SA
sales of 1.49 billion Brazilian Reals [US$266.07 million]
of which 100%
was auxiliary diagnostic support services),
(2.97 billion Brazilian Reals [US$529.22 million]
of which 82%
was Diagnostic Medicine), and
Diagnosticos Da America SA
(7.04 billion Brazilian Reals [US$1.25 billion]
of which 62%
Hypera SA reported sales of 4.09 billion Brazilian Reals (US$728.19 million)
December of 2020.
increase of 24.1%
versus 2019, when the company's sales were 3.29 billion Brazilian Reals.